Abstract
current methods that focus only on identifying direct associations between diseases and genetic 23 variants such as single-nucleotide polymorphisms (SNPs), our method introduces the effects of 24 intermediate phenotypes, which are related phenotypes distinct from the target, into the systematic 25 genetic study of diseases. Moreover, we consider multiple diseases simultaneously in a single model.
26
The procedure can be summarized in four steps: 1) selection of informative SNPs, 2) extraction of 27 latent variables from the selected SNPs, 3) investigation of the relationships among intermediate 28 phenotypes and diseases, and 4) construction of an SEM. As a result, a quantitative map can be drawn 29 that simultaneously shows the relationship among multiple SNPs, phenotypes, and diseases.
30
In this study, we considered two correlated diseases, hypertension and type 2 diabetes (T2D), which 31 are known to have a substantial overlap in their disease mechanism and have significant public health 32 implications. As intermediate phenotypes for these diseases, we considered three obesity-related 33 phenotypes-subscapular skin fold thickness, body mass index, and waist circumference-as traits 34 representing subcutaneous adiposity, overall adiposity, and abdominal adiposity, respectively. Using
35
GWAS data collected from the Korea Association Resource (KARE) project, we applied the proposed 36 SEM process. Among 327,872 SNPs, 24 informative SNPs were selected in the first step (p<1.0E-05).
37
Ten latent variables were generated in step 2. After an exploratory analysis, we established a path 38 diagram among phenotypes and diseases in step 3. Finally, in step 4, we produced a quantitative map 39 with paths moving from specific SNPs to hypertension through intermediate phenotypes and T2D.
40
The resulting model had high goodness-of fit measures ( = 536.52, NFI=0.997, CFI=0.998) . χ
Introduction

47
Hypertension and type 2 diabetes (T2D) are two of the leading risk factors for atherosclerotic 48 cardiovascular disease, which is a major component of the global burden of disease [1] [2] [3] [4] . These 49 conditions often occur together, and recent studies showed that the presence of T2D increased the risk 50 of hypertension [5, 6] . Hypertension and T2D are thought to share common pathways such as obesity,
51
insulin resistance, inflammation, oxidative stress, and mental stress [7] . In addition to lifestyle and 52 environmental factors, genetic factors have also been explored to understand the mechanisms of T2D
53
and hypertension [7, 8] . In particular, since obesity-related phenotypes are thought to be a common SNPs with a very low communality were excluded. Here, communality was considered to represent 130 the variance of any SNP that was shared with other SNPs via common factors.
131
The third step was to investigate the effect of intermediate phenotypes on diseases, or the associations 132 among all these phenotypic variables. This association analysis of multiple phenotypes provided a 133 conceptual framework for constructing an SEM structure in the following step.
134
In the final step, we applied SEM based on the previously constructed latent variables, or joint SNPs, calculated as the weight divided by the square of height (kg/m 2 ). SUB was measured using a caliper at 166 a vertical fold taken 1 inch below the lowest point of the shoulder blade (mm).
167
Hypertension was present in 2393 (27.06%) participants, and 836 (9.45%) of participants had T2DM.
168
The average( SD) values of the obesity-related variables were 24.60 kg/m 2 (±3.12 kg/m 2 ) for BMI, ± 169 23.69 mm (± 10.96 mm) for SUB, and 82.7 cm (± 8.79 cm) for WC (Table 1) . We analyzed these data 170 using the proposed procedure. From step 1 to step 3, statistical analyses were done using SAS version 
Results
176
Step 
185
In total, we considered 24 SNPs related with obesity, T2D, and hypertension. Step 2: Construction of latent variables for SNPs
191
To identify the underlying components, we conducted exploratory factor analysis. During factor 192 analysis, we investigated the communality between SNPs and constructed latent variables, and 193 excluded three SNPs with very low communality (less than 0.3): rs17178527, which was related to 194 BMI; rs16951883, which was related to SUB; and rs17092358, which was related to WC. A separate 195 factor analysis was performed for each phenotype to obtain latent variables for SNPs. Table 3 shows the factor loadings and variance explained for each phenotype. By using factor loadings, the four the seven WC-related SNPs were composed of three latent variables, (hereafter, LWC1, LWC2, and Step 3. Investigation of the relationships among variables 214 We investigated the association among phenotypes by adjusting for the effect of covariates including 215 area, sex, and age. Partial correlation coefficients of the considered phenotypes are presented in Table   216 4. according to recent studies [5, 6] . Next, we set up two major sets of paths regarding obesity indicators.
229
The first set of paths directly linked WC to T2D or hypertension because clinical evidence suggests that the association of insulin resistance (which is thought to be the key common pathway of T2D and 231 hypertension) with WC is stronger than the corresponding associations with BMI or SUB [22, 24] . In 232 the second set of paths, as BMI and SUB showed considerable correlations with WC, we established 233 distinct paths that connected BMI and SUB (1) via WC to T2D or hypertension and (2) directly, not 234 via WC. As a result, we considered the path from obesity to T2D and hypertension that is shown in AGFI=0.993, RMSEA=0.012), where NFI is the normed fit index, CFI is the comparative fit index,
253
GFI is the goodness of fit index, AGFI is the adjusted goodness of fit index, and RMSEA is the root 254 mean square error of approximation. hypertension. This analysis provides insights into the mechanisms underlying T2D and hypertension.
255
Fig 3 and
313
Our findings highlight the importance of subcutaneous adiposity and abdominal adiposity, as well as 
